Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lysyl Oxidase Regulates Epithelial Differentiation and Barrier Integrity in Eosinophilic Esophagitis.
Sasaki M, Hara T, Wang JX, Zhou Y, Kennedy KV, Umeweni CN, Alston MA, Spergel ZC, Ishikawa S, Teranishi R, Nakagawa R, Mcmillan EA, Whelan KA, Karakasheva TA, Hamilton KE, Ruffner MA, Muir AB. Sasaki M, et al. Among authors: teranishi r. Cell Mol Gastroenterol Hepatol. 2024;17(6):923-937. doi: 10.1016/j.jcmgh.2024.01.025. Epub 2024 Feb 9. Cell Mol Gastroenterol Hepatol. 2024. PMID: 38340809 Free PMC article.
The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry.
Teranishi R, Takahashi T, Sato S, Sakurai K, Kishi K, Hosogi H, Nakai T, Kurokawa Y, Fujita J, Nishida T, Hirota S, Tsujinaka T. Teranishi R, et al. Gastric Cancer. 2024 Mar;27(2):355-365. doi: 10.1007/s10120-023-01444-8. Epub 2023 Dec 25. Gastric Cancer. 2024. PMID: 38146035 Free PMC article.
Corrigendum to "Long-term survival and prognostic factors associated with curative conversion surgery for cT4b esophageal squamous cell carcinoma: Analysis of 200 consecutive cases": Surgery. 2023 Sep;174(3):558-566. doi:10.1016/j.surg.2023.05.040.
Teranishi R, Makino T, Tanaka K, Yamashita K, Saito T, Yamamoto K, Takahashi T, Kurokawa Y, Motoori M, Yamasaki M, Nakajima K, Eguchi H, Doki Y. Teranishi R, et al. Surgery. 2023 Nov;174(5):1277. doi: 10.1016/j.surg.2023.08.027. Epub 2023 Sep 9. Surgery. 2023. PMID: 37679251 No abstract available.
Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST.
Teranishi R, Takahashi T, Nishida T, Kurokawa Y, Nakajima K, Koh M, Nishigaki T, Saito T, Yamamoto K, Yamashita K, Tanaka K, Makino T, Motoori M, Omori T, Hirota S, Hayashi Y, Takehara T, Eguchi H, Doki Y. Teranishi R, et al. Int J Clin Oncol. 2023 May;28(5):680-687. doi: 10.1007/s10147-023-02325-x. Epub 2023 Mar 27. Int J Clin Oncol. 2023. PMID: 36971916
Combination of pimitespib (TAS-116) with sunitinib is an effective therapy for imatinib-resistant gastrointestinal stromal tumors.
Teranishi R, Takahashi T, Obata Y, Nishida T, Ohkubo S, Kazuno H, Saito Y, Serada S, Fujimoto M, Kurokawa Y, Saito T, Yamamoto K, Yamashita K, Tanaka K, Makino T, Nakajima K, Hirota S, Naka T, Eguchi H, Doki Y. Teranishi R, et al. Int J Cancer. 2023 Jun 15;152(12):2580-2593. doi: 10.1002/ijc.34461. Epub 2023 Feb 21. Int J Cancer. 2023. PMID: 36752576
71 results